Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $40.6600 (0.94%) ($40.6300 - $40.6600) on Thu. Apr. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.1% (three month average) | RSI | 46 | Latest Price | $40.6600(0.94%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.9% a day on average for past five trading days. | Weekly Trend | EDIT declines -3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(65%) IWO(61%) IWC(59%) IBUY(58%) IWM(56%) | Factors Impacting EDIT price | EDIT will decline at least -2.55% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-12%) TBT(-7%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.55% (StdDev 5.1%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $43.41 | 5 Day Moving Average | $41.88(-2.91%) | 10 Day Moving Average | $41.42(-1.83%) | 20 Day Moving Average | $43.41(-6.33%) | To recent high | -55.3% | To recent low | 2.2% | Market Cap | $2.525b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |